Mason KA - Search Results

1

Improvement of radiotherapy or chemoradiotherapy by targeting COX-2 enzyme.

Milas L, Mason KA, Crane CH, Liao Z, Masferrer J. Milas L, et al. Among authors: mason ka. Oncology (Williston Park). 2003 May;17(5 Suppl 5):15-24. Oncology (Williston Park). 2003. PMID: 12800601 Review.

2

Chemoradiotherapy: emerging treatment improvement strategies.

Milas L, Mason KA, Liao Z, Ang KK. Milas L, et al. Among authors: mason ka. Head Neck. 2003 Feb;25(2):152-67. doi: 10.1002/hed.10232. Head Neck. 2003. PMID: 12509799 Review.

3

Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors.

Nakata E, Mason KA, Hunter N, Husain A, Raju U, Liao Z, Ang KK, Milas L. Nakata E, et al. Among authors: mason ka. Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):369-75. doi: 10.1016/j.ijrobp.2003.09.061. Int J Radiat Oncol Biol Phys. 2004. PMID: 14751505

4

Cyclo-oxygenase-2 and its inhibition in cancer: is there a role?

Liao Z, Mason KA, Milas L. Liao Z, et al. Among authors: mason ka. Drugs. 2007;67(6):821-45. doi: 10.2165/00003495-200767060-00001. Drugs. 2007. PMID: 17428102 Review.

5

Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability.

Milas L, Mason KA, Hunter N, Li C, Wallace S. Milas L, et al. Among authors: mason ka. Int J Radiat Oncol Biol Phys. 2003 Mar 1;55(3):707-12. doi: 10.1016/s0360-3016(02)04153-6. Int J Radiat Oncol Biol Phys. 2003. PMID: 12573758

6

Role of cyclooxygenase-2 inhibitors in combination with radiation therapy in lung cancer.

Liao Z, Komaki R, Mason KA, Milas L. Liao Z, et al. Among authors: mason ka. Clin Lung Cancer. 2003 May;4(6):356-65. doi: 10.3816/clc.2003.n.015. Clin Lung Cancer. 2003. PMID: 14599301

7

Epidermal growth factor receptor as a target to improve treatment of lung cancer.

Andratschke NH, Dittmann KH, Mason KA, Fan Z, Liao Z, Komaki R, Ang KK, Milas L. Andratschke NH, et al. Among authors: mason ka. Clin Lung Cancer. 2004 May;5(6):340-52. doi: 10.3816/CLC.2004.n.012. Clin Lung Cancer. 2004. PMID: 15217533 Review.

8

CpG oligodeoxynucleotide enhances tumor response to radiation.

Milas L, Mason KA, Ariga H, Hunter N, Neal R, Valdecanas D, Krieg AM, Whisnant JK. Milas L, et al. Among authors: mason ka. Cancer Res. 2004 Aug 1;64(15):5074-7. doi: 10.1158/0008-5472.CAN-04-0926. Cancer Res. 2004. PMID: 15289307

9

Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.

Mason KA, Ariga H, Neal R, Valdecanas D, Hunter N, Krieg AM, Whisnant JK, Milas L. Mason KA, et al. Clin Cancer Res. 2005 Jan 1;11(1):361-9. Clin Cancer Res. 2005. PMID: 15671567

10

Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases.

Raju U, Ariga H, Koto M, Lu X, Pickett J, Valdecanas D, Mason KA, Milas L. Raju U, et al. Among authors: mason ka. Radiother Oncol. 2006 Aug;80(2):185-91. doi: 10.1016/j.radonc.2006.07.027. Epub 2006 Aug 14. Radiother Oncol. 2006. PMID: 16905211

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters